Chinese Medicine Regulatory Office
Site Menu
Notices
What's New
For latest Government press release, you may visit the HKSAR website.
- DH investigates suspected illegal possession of unregistered proprietary Chinese medicine (5 June 2023)
- The reference DNA sequence library of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” has been updated in June 2023 (1 June 2023)
- Recall of Chinese herbal medicines exceeding limits for aflatoxins (28 February 2023)
- The 6th to 10th monographs of project “Identification of Tiny Seed and Fruit Types of Chinese Materia Medica” have been published in February 2023 (27 February 2023)
- DH hosts Standing Committee Meeting and International Symposium of Western Pacific Regional Forum for the Harmonization of Herbal Medicines (with photos) (23 February 2023)
- Health Bureau and Department of Health meet National Medical Products Administration delegation (with photos) (13 February 2023)
- Consultation for the Amendment of Schedule 1 and Schedule 2 of the Chinese Medicine Ordinance (Cap. 549) (13 January 2023)
- First 5 monographs of project “Identification of Tiny Seed and Fruit Types of Chinese Materia Medica” have been published in December 2022 (1 December 2022)
- Five monographs of project “Study on the Identification of ZiziphiSpinosaeSemen and Its Commonly Confused Species” have been published in November 2022 (30 November 2022)
- The reference DNA sequence library of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” has been updated in November 2022 (30 November 2022)
- DH investigates poisoning case involving undeclared Western drug ingredient detected in yellowish tablets (with photo) (10 September 2022)
- DH hosted 12th Meeting of International Advisory Board on Hong Kong Chinese Materia Medica Standards (with photo) (17 August 2022)
- DH participates in 1st National Conference of Traditional Chinese Medicines Scientific Supervision (15 July 2022) (15 July 2022)
- The reference DNA sequence library of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” has been updated in June 2022 (1 June 2022)
- DH endorses recall of Chinese herbal medicines detected with pesticide residues by licensed Chinese herbal medicines wholesalers (17 May 2022)
- DH takes action to combat illegal sale or possession of unregistered medicines in medicine shops (with photos) (22 February 2022)
- Letter to Chinese medicine practitioner: COVID-19 - Letter to Chinese medicine practitioners: A surge of local cases (Chinese version only) (10 February 2022)
- DH hosts 19th Standing Committee Meeting of Western Pacific Regional Forum for the Harmonization of Herbal Medicines (20 January 2022)
- FHB welcomes approval of first batch of products for sale in Mainland under streamlined procedures for HK registered traditional pCms for external use to be registered in GBA(31 December 2021)
- Amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong(Chinese version only) (16 December 2021)
- The reference DNA sequence library of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” has been updated in November 2021 (29 November 2021)
- DH investigates case of undeclared Western drug ingredients detected in cream product prescribed by registered Chinese medicine practitioner (with photo) (25 October 2021)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation(29 September 2021)
- Arrangement for recruiting HK Chinese medicine practitioners (CMPs) by GBA public healthcare institutions (29 September 2021)
- Streamlining approval procedures for HK registered traditional pCms for external use to be registered in GBA (29 September 2021)
- DH investigates suspected illegal possession of unregistered proprietary Chinese medicines (with photo) (16 September 2021)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation (30 July 2021)
- Hong Kong and Mainland sign co-operation agreement on research for testing and standards of Chinese medicines (with photos) (15 June 2021)
- Setting limits of sulphur dioxide residue in Chinese herbal medicines and revised measures for implementation (Chinese version only) (27 May 2021)
- The reference DNA sequence library of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” has been updated in April 2021(13 April 2021)
- Consultation on amendments to the limits for harmful residues in Chinese herbal medicines in Hong Kong commences (31 March 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Local epidemic situation and latest arrangements of vaccination programme (Chinese version only) (16 March 2021)
- The 81st to 90th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in March 2021 (10 March 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Latest situation and vaccination arrangement (Chinese version only) (22 February 2021)
- DH endorses batch recall of mercury-tainted proprietary Chinese medicine (with photo)(3 February 2021)
- Letter to Chinese medicine practitioner: COVID-19 - Ongoing epidemic (Chinese version only) (27 January 2021) Letter | Appendix
- Results of Hong Kong Chinese Materia Medica Standards (Phase X) announced (22 December 2020)
- Department of Health mounts joint operation with Hong Kong Customs and investigates a case involving Chinese medicine granules for prescription with suspected false claim (with photo) (18 December 2020)
- Letter to Chinese medicine practitioner: COVID-19 - A surge of local cases and new round of anti-epidemic measures (Chinese version only) (17 December 2020) Letter | Appendix
- The 71st to 80th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in December 2020(2 December 2020)
- List of proprietary Chinese medicines with label or package insert not complied with the Chinese Medicines Regulation (3 November 2020)
- DH investigates case of undeclared Western drug ingredients detected in cream products prescribed by registered Chinese medicine practitioner (with photo) (2 November 2020)
- New analytical methods of project “Analysis of Cornu Cervi Pantotrichum by DNA Method as a Complementary Approach” have been published in November 2020 (2 November 2020)
- New analytical methods of project “Reference DNA Sequence Library for Chinese Materia Medica (CMMRSL)” have been published in November 2020 (2 November 2020)
- Letter to Wholesalers of Proprietary Chinese Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines (Chinese version only) (6 October 2020)
- Letter to Wholesalers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only) (6 October 2020)
- Letter to Retailers of Chinese Herbal Medicines from Department of Health: Import and Export of Proprietary Chinese Medicines and Chinese Herbal Medicines and Sale of Chinese Herbal Medicines via the Internet (Chinese version only) (6 October 2020)
- Recall of Chinese medicine granules with failed microbial limit (with photo) (28 September 2020)
- The 61st to 70th monographs of project “Identification of Easily Confused Species of Chinese Materia Medica in Hong Kong by Macroscopic and Microscopic Characteristics” have been published in September 2020(8 September 2020)
Latest Activities
- The roving exhibition on Chinese medicine will be held on 12-15 June 2023 in Wo Che Plaza in Sha Tin
- The roving exhibition on Chinese medicine will be held on 5-8 June 2023 in Kai Tin Shopping Centre in Lam Tin